3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
Cisplatin
7
Paclitaxel
4
toripalimab
3
Radiotherapy
3
Docetaxel
3
camrelizumab
2
Surveys and Questionnaires
2
Gemcitabine
2
Fluorouracil
2
nimotuzumab
1
nedaplatin
1
fluoromisonidazole
1
Surgical Procedures, Operative
1
Rubidium-82
1
Ritonavir
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Narrow Band Imaging
1
Magnetic Resonance Spectroscopy
1
Liquid Biopsy
1
Induction Chemotherapy
1
Indinavir
1
Home Environment
1
Fluorodeoxyglucose F18
1
Counseling
1
Chemoradiotherapy
1
Capecitabine
1
Blood Specimen Collection
1
Amifostine
1
5-fluoropentyl-2-methylmalonic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hypopharyngeal Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT06016699
2023-08-30
PRO-IMMUNO
University Medical Center Groningen
Unknown
40 enrolled